Pulmonary arterial hypertension: current therapeutic strategies

被引：0
|
作者：
Aniket Puri
Michael D McGoon
Sudhir S Kushwaha
机构：
[1] A Puri is a Senior Research Associate in Cardiology at King George's Medical University,
[2] Lucknow,undefined
[3] India.,undefined
[4] MD McGoon is Professor of Medicine and Director of the Pulmonary Hypertension Clinic at Mayo Clinic.,undefined
[5] SS Kushwaha is an Associate Professor of Medicine and Consultant in Cardiology at Mayo Clinic,undefined
[6] Rochester,undefined
[7] MN,undefined
[8] USA.,undefined
来源：
Nature Clinical Practice Cardiovascular Medicine | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pulmonary arterial hypertension (PAH) was once a lethal condition. As the number of therapeutic options available has risen, however, the treatment of PAH has evolved considerably. In this Review, Aniket Puri, Michael McGoon and Sudhir Kushwaha consider the current knowledge of the pathogenesis of PAH in relation to presently available and novel emerging therapies, including combination therapy, that hold promise for treatment as well as disease modification.
引用
收藏
页码：319 / 329
页数：10
相关论文
共 50 条
  • [31] Promising therapeutic approaches in pulmonary arterial hypertension
    Ali, Md Khadem
    Ichimura, Kenzo
    Spiekerkoetter, Edda
    CURRENT OPINION IN PHARMACOLOGY, 2021, 59 : 127 - 139
  • [32] Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
    Kim, Hyung Yoon
    Kim, Kye Hun
    KOREAN CIRCULATION JOURNAL, 2019, 49 (04) : 361 - 362
  • [33] New Therapeutic Target for Pulmonary Arterial Hypertension
    Yoon, Kyung Lim
    KOREAN CIRCULATION JOURNAL, 2018, 48 (12) : 1145 - 1147
  • [34] Pulmonary arterial hypertension: New therapeutic modalities
    Pitsiou, G. G.
    Argiropoulou-Pataka, P.
    PNEUMON, 2005, 18 (02) : 144 - 155
  • [35] Novel therapeutic targets in pulmonary arterial hypertension
    Morrell, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 15 - 15
  • [36] Therapeutic innovations to cure pulmonary arterial hypertension
    Humbert, Marc
    PRESSE MEDICALE, 2011, 40 : 1 - 2
  • [37] Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential
    Koerbelin, Jakob
    Klein, Julius
    Matuszcak, Christiane
    Runge, Johannes
    Harbaum, Lars
    Klose, Hans
    Hennigs, Jan K.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
  • [38] Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension
    Lange, Tobias J.
    HERZ, 2023, 48 (04) : 259 - 265
  • [39] Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
    Madonna, Rosalinda
    Cocco, Nino
    CURRENT DRUG TARGETS, 2016, 17 (07) : 817 - 823
  • [40] THERAPEUTIC CHALLENGES OF HIV-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IN THE CURRENT ANTIRETROVIRAL THERAPY
    Abdullah, Maie
    Mwangi, John K.
    CHEST, 2024, 166 (04) : 6069A - 6069A
12345